Article Information
History
- October 2, 2023.
Article Versions
- Version 1 (July 23, 2023 - 08:31).
- You are viewing Version 2, the most recent version of this article.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY 4.0 International license.
Author Information
- Xueyang Pan1,2,
- Albert N. Alvarez3,
- Mengqi Ma1,2,
- Shenzhao Lu1,2,
- Michael W. Crawford3,
- Lauren C. Briere4,
- Oguz Kanca1,2,
- Shinya Yamamoto1,2,5,
- David A. Sweetser4,6,
- Jenny L. Wilson7,
- Ruth J. Napier3,8,9,
- Jonathan N. Pruneda3,# and
- Hugo J. Bellen1,2,5,#
- 1Department of Molecular and Human Genetics, Baylor College of Medicine, Houston, TX 77030, USA
- 2Jan & Dan Duncan Neurological Research Institute, Texas Children’s Hospital, Houston, TX 77030, USA
- 3Department of Molecular Microbiology & Immunology, Oregon Health & Science University, Portland, OR 97239, USA
- 4Center for Genomic Medicine, Massachusetts General Hospital, Boston, MA 02114, USA
- 5Department of Neuroscience, Baylor College of Medicine, Houston, TX 77030, USA
- 6Division of Medical Genetics & Metabolism, Massachusetts General Hospital for Children, Boston, MA 02114, USA
- 7Division of Pediatric Neurology, Department of Pediatrics, Oregon Health & Science University, Portland, OR 97239, USA
- 8VA Portland Health Care System, Portland, OR 97239, USA
- 9Division of Arthritis & Rheumatic Diseases, Oregon Health & Science University, Portland, OR 97239, USA
- ↵#Correspondence: hbellen{at}bcm.edu, pruneda{at}ohsu.edu
Posted October 02, 2023.
Allelic strengths of encephalopathy-associated UBA5 variants correlate between in vivo and in vitro assays
